Bears bring little comfort to young lions of life sciences
This article was originally published in Clinica
Executive Summary
The European life sciences sector had a disappointing year, with most companies ending 1997 with share prices substantially below the levels they were at 12 months before. Nick Woolf looks at the stock market performance of some of the medical device and diagnostic companies in the sector.